CollPlant Biotechnologies (CLGN) Enterprise Value Growth (1y) (2018 - 2025)
CollPlant Biotechnologies (CLGN) Enterprise Value Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 97.71% |
| Jun 30, 2025 | 38.89% |
| Dec 31, 2024 | -865.67% |
| Sep 30, 2024 | -0.55% |
| Jun 30, 2024 | 15.25% |
| Mar 31, 2024 | -782.52% |
| Dec 31, 2023 | 87.65% |
| Sep 30, 2023 | -672.67% |
| Jun 30, 2023 | 38.40% |
| Mar 31, 2023 | 27.46% |
| Dec 31, 2022 | 99.90% |
| Sep 30, 2022 | -26.06% |
| Jun 30, 2022 | -105.52% |
| Mar 31, 2022 | 78.60% |
| Dec 31, 2021 | -5,746,140.84% |
| Sep 30, 2021 | -386.04% |
| Jun 30, 2021 | -344.33% |
| Mar 31, 2021 | -3,158.44% |
| Dec 31, 2020 | 97.84% |
| Sep 30, 2020 | 8.84% |